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1 Introduction
Non-immune hydrops fetalis (NIHF), caused by
disorders other than feto-maternal blood group
incompatibility, is the predominant form of hy-
drops fetalis in developed countries [1]. Though
hydrops fetalis can be readily diagnosed antena-
tally using ultrasound, NIHF is still associated
with an extremely high perinatal mortality [8].
Although many fetopathies associated with NIHF
have been reported, the etiology and the underly-
ing disorders cannot be determined in approxi-
mately 30 percent [14]. In these cases of idiopathic
hydrops fetalis (IHF), a characteristic and com-
mon finding is hypoproteinemia [11]. The de-
creased serum protein concentration may play an
important role in establishing the clinical picture
of hydrops fetalis.
Based on the hypothesis that decreased plasma
colloid osmotic pressure due to hypoproteinemia
may play a role in the onset and/or progress of
IHF, we injected albumin into the fetal abdominal
cavity and thus attempted to save the lives of
fetuses with IHF.
2 Materials and methods
Thirty-three infants with NIHF, diagnosed ante-
natally, were delivered in the Maternity Care Unit
of Kyushu University Hospital from January 1983
to December 1986. There were eleven with IHF
(table I). Seven of these eleven were treated in
utero. The other four were excluded from the
present study. In one case because delivery and
neonatal treatment were decided upon because
the gestational age (36 weeks) was thought to be
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sufficiently advanced. In three others, the parents
refused intrauterine treatment. All four died soon
after birth despite active resuscitation and respir-
atory care in the NICU.
The protocol for the intrauterine treatment of
NIHF consisted of the following: attempts to
evaluate the etiology and the underlying disorder;
the intrauterine treatment; and the evaluation of
therapeutic effects in utero. Intrauterine treatment
was performed after obtaining informed consent
from the families.
To assess the etiology and the underlying disorders,
the following tests were done on the mother: com-
plete blood count, blood group, blood-group anti-
body, Hb F concentration, TORCH screening
tests and oral glucose tolerance test. In the fetus,
detailed ultrasound examination of the fetal anat-
omy, fetal echocardiography, optical density dif-
ference at 450 nm in amniotic fluid, and karyotype
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Double outlet of right ventricle
Complete atrioventricular block
Decreased fractional shortening of both
ventricles of unknown origin
























All infants were delivered in the Maternity Care Unit
of Kyushu University Hospital from January 1983 to
December 1986.
of amniotic fluid fibroblasts were done. When the
etiology and the underlying disorder could not be
determined, hydrops fetalis was diagnosed antena-
tally as IHR
Intrauterine treatment comprised the following:
Firstly, in order to maintain and increase serum
protein concentration, albumin and/or packed red
blood cells (PRC) were injected into the fetal ab-
dominal cavity using ultrasound visualization.
The amount of albumin injected was two to four
grams added to the total amount of protein con-
tained in the ascitic fluid removed from the fetus.
The amount of PRC injected was determined ac-
cording to BOWMAN'S method [3]. Serial paracen-
teses and thoracocenteses were performed to de-
compress the thoracic cavities.
To evaluate the therapeutic effects in utero,
changes in the degree of edema, ascites and pleural
effusion were determined, using real-time ultra-
sound at least once a week, and the hourly fetal
urine production rate (HFUPR) was measured
both immediately before and 24 hours after the
intrauterine treatment was performed, using the
method of CAMPBELL et al. [4]. In brief, HFUPR
was calculated after the fetal bladder volume was
observed every five minutes for a three hours
period, using real-time ultrasound. When HFUPR
increased to 150 percent or more within 24 hours
after the intrauterine treatment, there was judged
to be an "increase of HFUPR". Fetal cardiac
function was evaluated by fetal echocardiography
once a week.
Fetal well-being was monitored by using cardio-
tocography at least once a day. Fetal lung matura-
tion was estimated by means of the lecithin/
sphingomyelin (L/S) ratio in the amniotic fluid.
When edema and fluid accumulation in serous
cavities increased despite intrauterine treatment,
and/or when fetal distress was evident on the
cardiotocogram, the pregnancy was terminated in
order to give immediate treatment to the neonate.
3 Results
At the time of initial diagnosis, the gestational age
ranged from 26 to 32 weeks. All fetuses had edema
(skin thickness over 5 mm [7]). Two had pleural
effusion alone, three had only ascites, and two
had both pleural effusion and ascites (table II).
Injection of albumin and/or PRC into the fetal
abdominal cavity was performed twice in six cases
and four times in one, at intervals of 10 to 14 days.
Abdominal paracenteses were performed twice in
two, three times in one and four times in two.
Thoracocenteses were performed once in two
cases and three times in one.
With respect to evaluation of the effects of ther-
apy, the HFUPR was measured before and after
the intrauterine treatment in five. In three of these
five, the HFUPR increased. In no case did the
HFUPR decrease. In two in whom the HFUPR
did not increase, one had a negative balance of
protein, and in the other, the serum protein con-
centration increased from 2.0 g/dl immediately
before the second injection to 2.9 g/dl at delivery.
This infant was delivered six days after the second
injection. In two with no pleural effusion, the
HFUPR increased, but it increased in only one of
three with pleural effusion (table II).
In one (case 6), signs of hydrops fetalis disap-
peared completely in utero, and edema decreased
significantly in case 7. In the other five, signs of
hydrops fetalis remained unchanged in utero.
The cardiotocogram revealed no ominous signs in
six. In one (case 2), the cardiotocogram revealed
late decelerations during labor.
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There were no stillbirths. Gestational age at birth
ranged from 33 to 40 weeks. The interval between
the initial diagnosis and the delivery ranged from
3 to 14 weeks. Apgar scores at one minute were
3 or less in three, 4 to 6 in two, and 7 or over in
two. The umbilical artery pH was less than 7.15
in two, 7.15 to 7.19 in one and 7.20 or over in
three. In one with an Apgar score of 9 at one
minute, the umbilical artery pH was not measured
(table III).
The laboratory data derived from the cord blood
is shown in table IV. One had anemia; the values
of serum protein were less than 3.0 g/dl in two,
3.0 to 4.0 g/dl in one, and 4.0 g/dl or over in
four.
Four with pleural effusion died of respiratory
failure within 24 hours after delivery. The weight
of the lungs was significantly low. Two of three
without pleural effusion survived. One without
pleural effusion died of sepsis on the fifth day
(table IV). In all cases, the etiology and the under-
lying disorders were not detected in examinations
done throughout the neonatal period and at au-
topsy.










Time of Ultrasonic manifestation
diagnosis
(weeks) Edema Ascites Pleural
Head Trunk
29 + + +
27 + + + +
28 + + + +
32 + + ± ±
30 + + +
26 - + + -


























1 Fetal urine production rate,2 Cardiotocogram,3 Bilateral fractional shortening of ventricles, 4 normal pattern,5 no
change



























































































1 Umbilical artery, 2 Cesarean section, 3 Vaginal
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Table IV. Laboratory data on cord blood in seven neonates with IHF
1
Intake/Output balance
Amount of transfused albumin (g)
Amount of transfused RBC (ml)

















































































A standard protocol for the management of NIHF
has not been established, though hydrops fetalis
due to tachyarrhythmia has been successfully
treated during the perinatal period [10].
It remains controversial whether intrauterine
treatment is sufficiently effective to save the life
of the infant with NIHF. ETCHES and LEMONS [6]
suggested that early diagnosis and delivery early
in the third trimester of pregnancy, plus aggressive
neonatal treatment, may improve the survival rate
of those with NIHF. WATSON and CAMPBELL [14]
reported that early diagnosis and antenatal treat-
ment did not improve the outcome in NIHF, ex-
cept for those due to cardiac arrythmia. However,
they treated NIHF due to disorders other than
cardiac arrythmia with abdominal paracenteses
and thoracocenteses alone. We [12] reported that
two fetuses with NIHF due to disorders other
than tachyarrythmia were effectively treated in
utero.
It has been reported that decreased plasma colloid
osmotic pressure due to hypoproteinemia may
play an important role in the onset and/or the
progression of NIHF [2, 11], though the etiology
of NIHF is heterogenous. The objective of intra-
uterine treatment is to curtail the pathophysiol-
ogic process and to preserve the fetus in good or
fair condition until the optimal time to treat the
IHF, postnatally is reached. For this purpose,
albumin and/or PRC were injected into the fetal
abdomen to maintain the fetal plasma colloid
osmotic pressure. In the present study, evidence
for progression of the hydropic changes was not
seen and indeed signs of hydrops fetalis disap-
peared in utero in one, and skin thickness de-
creased in another. In three of the five cases in
whom the HFUPR was measured, it increased
within 24 hours after albumin injections. This
result suggests that renal blood flow increased
after the albumin injection, because changes in
the HFUPR may reflect a change of renal blood
flow [9]. In addition, the concentration of serum
protein increased from 2.0 to 2.9 g/dl, six days
after albumin injection in one, in whom fetal
blood sampling was done. The increase of serum
protein following albumin injection into the fetal
abdomen may lead to an increase in plasma vol-
ume due to a shift of extracellular fluid from the
extravascular to the intravascular compartment.
Thus, albumin injection into the fetal abdominal
cavity fulfilled the intention of maintaining fetal
plasma colloid osmotic pressure. However, evi-
dence that in two of the three with pleural effusion
the HFUPR did not increase suggests that pleural
effusion may inhibit the return of circulating
blood into the heart due to an elevated intrathor-
acic pressure.
There is a significant difference between the out-
come of IHF with pleural effusion and IHF
without pleural effusion. SHIMOKAWA et al. [13]
and CASTILLO et al. [5] reported that severe pleural
effusion correlated with poor perinatal outcome
because of it's association with hypoplastic lungs.
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Four of the babies with pleural effusion died of
respiratory failure during the neonatal period, re-
gardless of the intrauterine treatment they re-
ceived and aggressive respiratory care given after
birth. In addition, their lungs were significantly
light in weight. In the present study, the cause and
effect between the pleural effusion and hypoplastic
lungs could not be determined because pleural
effusion re-accumulated within 24 hours after
thoracocenteses. WEINER et al. [15] reported that
NIHF was treated successfully in utero, using
continuous drainage of pleural effusion. There-
fore, it may be advantageous to place an indwell-
ing catheter into the thoracic cavity in cases of
NIHF who have pleural effusions.
In conclusion, albumin injection into the fetal
abdominal cavity is an effective procedure in order
to save the life of a fetus with IHF but without
pleural effusion. Although, in a case of IHF with
pleural effusion, the procedure is effective in main-
taining the fetal plasma colloid osmotic pressure,
other therapy will have to be developed in order
to enhance growth of the lungs.
Summary
Seven fetuses with idiopathic hydrops fetalis (IHF) were
treated in utero by injecting albumin into the fetal ab-
dominal cavity and by removal of accumulated fluid
from the serous cavities.
Signs of hydrops fetalis disappeared in utero in one, and
skin edema significantly decreased in another. In the
other five, signs of hydrops fetalis remained unchanged
in utero. The hourly fetal urine production rate
(HFUPR) increased after albumin injection in three of
five. The interval between the initial diagnosis and deliv-
ery ranged from 3 to 14 weeks. Gestational age at the
time of delivery ranged from 33 to 40 weeks.
There were no stillbirths. Two of three without pleural
effusion survived, but four with pleural effusion died of
respiratory failure during the neonatal period due to
pulmonary hypoplasia.
These results indicate that albumin injection into the
fetal abdomen in utero deserves further attention and
that other therapeutic methods should be established
to enhance the development of the lungs in cases of
intrauterine treatment of IHF with pleural effusion.
Keywords: Fetotherapy, idiopathic hydrops fetalis, ultrasound.
Zusammenfassung
Intrauterine Behandlung des idiopathischen Hydrops feta-
lis
Wir behandelten 7 Feten mit idiopathischem Hydrops
fetalis (IHF) intrauterin durch Albumininjektionen in
die fetale Bauchhöhle mit anschließender wiederholter
Punktion der gebildeten Flüssigkeitsansammlungen aus
den serösen Höhlen.
Bei einem Feten gingen die Symptome völlig zurück, bei
einem zweiten nahm das Hautödem deutlich ab. In 5
Fällen trat in utero keine Veränderung ein. Die fetale
stündliche Urinproduktion nahm in 3 Fällen nach Albu-
mininjektion in das fetale Abdomen zu. Das Intervall
zwischen Erstdiagnose und Entbindung lag zwischen 3
und 14 Wochen, das Gestationsalter bei Geburt zwischen
33 und 40 Wochen.
Totgeburten traten nicht auf. 2 von 3 Kindern ohne
Pleuraerguß überlebten, 4 mit Pleuraerguß starben je-
doch an einem respiratorischen Versagen infolge hypo-
plastischer Lungen in der Neonatalperiode.
Die Ergebnisse zeigen, daß Albumininjektionen in das
fetale Abdomen weitere Beachtung finden sollten und
daß ein therapeutischer Zugang zur Entwicklung der
Lungen bei IHF mit Pleuraerguß erarbeitet werden muß.
Schlüsselwörter: Fetale Therapie, idiopathischer Hydrops fetalis, Ultraschall.
Resume
Traitement in utero de l'hydrops fcetalis idiopathique
Sept foetus avec hydrops idiopathique (I. H. F.) ont ete
traites in utero par injection d'albumine dans la cavite
abdominale du foetus et par evacuation du liquide accu-
mule dans Fabdomen.
Les signes de Fhydrops ont disparu in utero chez Tun
de ces /oetus et Foedeme epidermique a diminue conside-
rablement chez un autre. Pour les 5 autres foetus, les
signes d'hydrops n'ont pas varie in utero. Le taux de
production d'urine foetale par heure (HFUPR) a aug-
mente apres Finjection d'albumine dans Fabdomen chez
3 de ces foetus.
L'intervalle entre le diagnostic initial et Faccouchement
etait de 3 ä 14 semaines. L'äge de gestation au moment
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de l'accouchement etait compris entre 33 et 40 semaines.
II n'y a eu aucun cas mort-ne. Deux des trois foetus
sans liquide pleural ont survecu, mais quatre foetus avec
liquide pleural sont morts de gene respiratoire dans la
periode neonatale en raison d'une hypoplasie pulmonai-
re.
Ces resultats manifestent que Pinjection d'albumine dans
1'abdomen foetal in utero est digne d'interet et que les
autres moyens therapeutiques doivent etre mis en oeuvre
pour activer le developpement des poumons dans les cas
de traitement in utero de Fhydrops foetalis idiopathique
avec epanchement pleural.
Mots-cles: Fcetotherapie, hydrops fetalis idiopathique, ultrasons.
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